Characteristics of a nickel–albumin binding assay for assessment of myocardial ischaemia

References

• Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. (2001). Characterization of the Co2+ and Ni2+ binding amino-acid residues of the N-terminus of human albumin. Eur J Biochem 268:42–7.
   PubMedGoogle Scholar
• Bar-Or D, Lau E, Winkler JV. (2000). A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia: a preliminary report. J Emerg Med 19:311–15.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Rael LT, Bar-Or R et al. (2008). The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 387:120–7.
   PubMed Web of Science ®Google Scholar
• Berenshtein E, Mayer B, Goldberg C, Kitrossky N, Chevion M. (1997). Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury. J Mol Cell Cardiol 29:3025–34.
   PubMed Web of Science ®Google Scholar
• Bhagavan NV, Ha JS, Park JH et al. (2009). Utility of serum fatty acid concentrations as a marker for acute myocardial infarction and their potential role in the formation of ischemia-modified albumin: a pilot study. Clin Chem 55:1588–90.
   PubMed Web of Science ®Google Scholar
• Brogan GX, Hollander JE, McCuskey CF et al. (1997). Evaluation of a new assay for cardiac troponin I vs. creatine kinase-MB for the diagnosis of acute myocardial infarction. Acad Emerg Med 4:6–12.
   PubMed Web of Science ®Google Scholar
• Cho DK, Choi JO, Kim SH et al. (2007). Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm. Coron Artery Dis 18:83–7.
   Google Scholar
• Christenson RH, Azzazy HME. (1998). Biochemical markers of the acute coronary syndromes. Clin Chem 44:1855–64.
   PubMedGoogle Scholar
• Christenson RH, Duh SH, Sanhai WR et al. (2001). Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 47:464–70.
   PubMed Web of Science ®Google Scholar
• Cichota LC, Moresco RN, Duarte MMMF, Silva JEP. (2008). Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal 22:1–5.
   PubMed Web of Science ®Google Scholar
• Cobbe SM, Poole-Wilson PA. (1980). The time of onset and severity of acidosis in myocardial ischemia. J Mol Cell Biol 12:745–60.
   Google Scholar
• Collinson PO, Gaze DC, Bainbridge K et al. (2006). Utility of admission cardiac troponin and ‘Ischemia Modified Albumin’ measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 23:256–61.
   PubMed Web of Science ®Google Scholar
• Duarte MMMF, Rocha JBT, Moresco RN et al. (2009). Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 42:666–71.
   PubMed Web of Science ®Google Scholar
• Joint European Society of Cardiology/American College of Cardiology Committee. (2000). Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21:1502–13.
   Google Scholar
• Keating L, Benger JR, Beetham R et al. (2006). The PRIMA Study: presentation ischaemia-modified albumin in the emergency department. Emerg Med J 23:764–8.
   PubMedGoogle Scholar
• Lee YW, Kim HJ, Cho YH, Shin HB, Choi TY, Lee YK. (2007). Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome. Clin Chim Acta 384:24–7.
   PubMed Web of Science ®Google Scholar
• Lippi G, Montagnana M, Salvagno GL, Guidi GC. (2007). Standardization of ischemia-modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 45:261–2.
   PubMed Web of Science ®Google Scholar
• Moresco RN, Vargas LCR, Halla-Júnior R, Silla LMR. (2005). Lack of association between cardiac troponin T and D-dimer in the evaluation of myocardial damage. J Clin Lab Anal 19:282–4.
   Google Scholar
• Peacock F, Morris DL, Anwaruddin S et al. (2006). Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 152:253–62.
   PubMed Web of Science ®Google Scholar
• Peters T. (1995). All About Albumin: biochemistry, genetics, and medical applications. Amsterdam: Elsevier. Available at: http://www.sciencedirect.com/science/book/9780125521109 (last accessed 19 March 2010).
   Google Scholar
• Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. (1977). The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation 56:786–94.
   PubMed Web of Science ®Google Scholar
• Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. (2006). Role of reactive oxygen species on the formation of the novel diagnostic marker ischemia modified albumin. Heart 92:113–14.
   PubMed Web of Science ®Google Scholar
• Sbarouni E, Georgiadou P, Theodorakis GN, Kremastinos DT. (2006). Ischemia-modified albumin in relation to exercise stress testing. J Am Coll Cardiol 48:2482–4.
   PubMed Web of Science ®Google Scholar
• Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. (2004). Role of ‘ischemia modified albumin’, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21:29–34.
   PubMed Web of Science ®Google Scholar